Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya

BACKGROUND: “FFM ME-TRAP” is sequential immunisation with two attenuated poxvirus vectors (FP9 and modified vaccinia virus Ankara) delivering the pre-erythrocytic malaria antigen ME-TRAP. Over nine months follow-up in our original study, there was no evidence that FFM ME-TRAP provided protection aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Bejon, Philip, Ogada, Edna, Mwangi, Tabitha, Milligan, Paul, Lang, Trudie, Fegan, Greg, Gilbert, Sarah C., Peshu, Norbert, Marsh, Kevin, Hill, Adrian V.S.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940326/
https://www.ncbi.nlm.nih.gov/pubmed/17710125
http://dx.doi.org/10.1371/journal.pone.0000707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940326/
https://www.ncbi.nlm.nih.gov/pubmed/17710125
http://dx.doi.org/10.1371/journal.pone.0000707

Ejemplares similares